Latest Abagovomab Stories
-- Animal model highly representative of late-stage ovarian cancer in women PHILADEPHIA, April 20, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Ltd, (ASX:NRT;
Journal of Clinical Oncology Research Looks at Value, Risk of Aggressive Surgery Pittsburgh, PA (PRWEB) February 10, 2015 Aggressive surgery to remove
ROCHESTER, N.Y., Dec. 9, 2014 /PRNewswire/ -- Vaccinex, Inc.
Trial will test the potential synergy between a taxane and TTFields in the treatment of recurrent ovarian cancer ST. HELIER, Jersey, Oct.
TSX Venture: QPT EDMONTON, June 9, 2014 /PRNewswire/ - Quest PharmaTech Inc.
New comprehensive research report “Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies”
Reportbuyer.com just published a new market research report:
A new antibody-guided drug has shown promising activity in a phase I trial involving ovarian cancer patients with platinum drug-resistant disease.
- A young chicken: also used as a pet name for children.